Back to search

Article

Response Predictors and Clonal Evolution during Thalidomide Therapy in Myelodysplastic Neoplasms with Increased Blasts

2026-08-25

Abstract excerpt

<title>Abstract</title> <p> Therapeutic options remain limited for patients with myelodysplastic neoplasms (MDS) with increased blasts who are ineligible for, intolerant of or decline hypomethylating agents (HMAs). We retrospectively investigated the efficacy, predictors of response, survival outcomes and clonal evolution of thalidomide in 56 patients with MDS and increased blasts. Among 50 evaluable patients, t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ce7a946-f573-54b5-a928-3900f1d2d677
DOI
10.21203/rs.3.rs-10536298/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Response Predictors and Clonal Evolution during Thalidomide Therapy in Myelodysplastic Neoplasms with Increased BlastsDOI 10.21203/rs.3.rs-10536298/v1
Select a neighboring publication to make it the new centre.